Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2014-05-14 Annual Report
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
103年年報及股東會資料 — 2013_3164_20140430F04.pdf
Annual Report Classification · 100% confidence The document is titled as an annual report for the fiscal year 102 (in the Taiwanese calendar, corresponding to 2013-2014) and includes detailed sections such as shareholder reports, company profile, corporate governance, capital raising, business overview, and financial overview. It contains comprehensive financial data, management discussion, auditor information, and detailed financial statements. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of auditor names and audit opinions further supports this classification. Therefore, this document is the official yearly report covering company activity and full financial performance, which corresponds to an Annual Report (10-K). FY 2013
2014-05-14 Chinese
103年年報及股東會資料 — 2014_3164_20140430F02.pdf
AGM Information Classification · 100% confidence The document is a detailed agenda and handbook for the Annual General Meeting (AGM) of GenMont Biotech Inc. for the year 103 (Taiwan calendar, corresponding to 2014). It includes the meeting procedures, agenda items such as reports, approvals, discussions, and elections, as well as multiple attachments including the 102-year business report, auditor's review report, financial statements, and company bylaws. The presence of detailed meeting agenda, election of directors, approval of financial statements, and other shareholder meeting activities clearly identifies this as materials shared during the Annual General Meeting. The document length is substantial (15,000 characters), and it contains the actual meeting handbook and related reports, not just an announcement of a report. Therefore, the correct classification is AGM Information (AGM-R).
2014-05-14 Chinese
103年年報及股東會資料 — 2014_3164_20140430F17.pdf
Major Shareholding Notification Classification · 95% confidence The document contains a table listing the top ten shareholders of a company, including their shareholdings, relationships among them, and related notes. This type of information is typically disclosed in filings related to major shareholding notifications or disclosures about significant shareholders and their relationships. There is no indication of financial statements, management discussion, or meeting materials. The document is focused on share ownership details and relationships among major shareholders, which aligns with the category for Major Shareholding Notification (MRQ). The document length is short and does not appear to be an announcement of a report publication or a regulatory filing of another type. Therefore, the best classification is Major Shareholding Notification (MRQ).
2014-05-14 Chinese
103年年報及股東會資料 — 2014_3164_20140430F13.pdf
AGM Information Classification · 95% confidence The document is a detailed agenda and explanatory materials for the Annual General Meeting (AGM) of GenMont Biotech Inc. It includes the meeting date, location, agenda items such as reports on the previous fiscal year, financial statements, investment reports, amendments to company bylaws, and election of directors. The content is typical of materials shared during an AGM to inform shareholders and facilitate voting. The document length is about 2710 characters, which is consistent with an AGM information document rather than a full annual report or financial statement. There is no indication that this is a full Annual Report (10-K) or an announcement of voting results (DVA). Therefore, the classification is AGM Information (AGM-R).
2014-05-14 Chinese
103年年報及股東會資料 — 2014_3164_20140430F01.pdf
AGM Information Classification · 95% confidence The document is a detailed notice and related materials for the 103rd Annual General Meeting (股東常會) of 景岳生物科技股份有限公司, including meeting agenda, proxy forms, voting instructions, and other shareholder meeting logistics. It contains no financial statements or management discussion of financial results, but rather focuses on the meeting arrangements, proxy solicitation, and voting procedures. The document length is about 4846 characters, which is consistent with a meeting notice and proxy materials rather than a full annual report or financial report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2014-05-14 Chinese
103年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment amounts, and investment income recognized for the period. The document is relatively short (1290 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. There is no indication of it being an annual or interim report, audit report, or earnings release. It also does not fit categories like management changes, voting results, or capital changes. The content aligns with a regulatory filing providing specific investment disclosures as required by authorities. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2014-05-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.